original ) (raw )Dimethyl dioctadecyl ammoniumbromide as an adjuvant for delayed type hypersensitivity and cellular immunity against Semliki Forest virus in mice
Harm Snippe
Archives of Virology, 1980
View PDFchevron_right
Dimethyl diotadecyl ammonium bromide as adjuvant for delayed hypersensitivity in mice
Harm Snippe
Immunology
View PDFchevron_right
Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies
Harm Snippe
Archives of Virology, 1988
View PDFchevron_right
Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies
G. Splitter
Journal of virology, 1998
View PDFchevron_right
Application of immunoassay of encephalomyocarditis virus in cell culture with enzyme-labeled virus-specific monoclonal antibodies for rapid detection of virus, neutralizing antibodies, and interferon
M. Harmsen
Journal of clinical microbiology, 1988
View PDFchevron_right
Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies
Moses Rodriguez
Journal of virology, 1989
View PDFchevron_right
Enhancement of delayed-type hypersensitivity and induction of interferon by the lipophilic agents DDA and CP-20,961
Harm Snippe , Barry Benaissa-Trouw
Cellular Immunology, 1982
View PDFchevron_right
Increased cellular immunity against host cell antigens induced by vacciniavirus
Ulrich Koszinowski
Archiv f�r die gesamte Virusforschung, 1974
View PDFchevron_right
Enhancement of encephalomyeloradiculitis in mice sensitized with spinal cord tissue and infected with lactate dehydrogenase-elevating virus
Margo Brinton
Journal of Neuroimmunology, 1985
View PDFchevron_right
In vitro proliferation of lymphocytes from cyclophosphamide-pretreated mice immunized with antigen mixed with dimethyl dioctadecyl ammonium bromide
Barry Ziola
Journal of Immunological Methods, 1987
View PDFchevron_right
Pathogenesis of the B variant of encephalomyocarditis virus
D. Roselyn Cerutis
Journal of Medical Virology, 1993
View PDFchevron_right
Immunomodulating properties of two synthetic adjuvants: Dependence upon type of antigen, dose, and time of administration
Harm Snippe , Margriet Jansze
Cellular Immunology, 1984
View PDFchevron_right
The efficacy of an experimental oil-adjuvanted encephalomyocarditis vaccine in elephants, mice and pigs
R. Bengis
Vaccine, 1998
View PDFchevron_right
Adjuvant enhancement of humoral immune response to chemically inactivated bovine viral diarrhea virus
Charles Muscoplat
PubMed, 1985
View PDFchevron_right
Detection of a shared idiotope on two encephalomyocarditis virus neutralizing monoclonal antibodies by neutralization inhibition enzyme immunoassay
M. Harmsen
Journal of Virological Methods, 1993
View PDFchevron_right
Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus
Anubha Saxena
International Immunopharmacology, 2013
View PDFchevron_right
High susceptibility to lipopolysaccharide-induced lethal shock in encephalomyocarditis virus-infected mice
Mitsuru Seishima
2012
View PDFchevron_right
Immunohistochemical Detection of Encephalomyocarditis Virus (EMCV) Antigen in the Heart of Experimentally Infected Piglets
O. Papadopoulos
Journal of Comparative Pathology, 2000
View PDFchevron_right
Potentiating effect of adjuvants on humural immunity to porcine parvovirus vaccines in guinea pigs
T. Molitor
Veterinary Microbiology, 1985
View PDFchevron_right
Effect of catanospermine, 1-deoxynojirimycin or 1-deoxymannojirimycin on biological and functional activities of Japanese encephalitis virus in porcine stable kidney cells
Ashok Kumar Gupta
Microbiology Research, 2013
View PDFchevron_right
Light and electron microscopic studies of mouse CNS after subcutaneous administration of the E and M variants of the encephalomyocarditis virus
Cheng-Yue Tsai
Acta Neuropathologica, 1973
View PDFchevron_right
Novel adjuvants for induction of T-cell and antibody responses to encephalitogenic and regulatory determinants in Lewis rats
I. Robey , Bruce Bebo
Vaccine, 1998
View PDFchevron_right
Delayed-type hypersensitivity responses in mice infected with St. Louis encephalitis virus: kinetics of the response and effects of immunoregulatory agents
James DeMartini
Infection and Immunity, 1979
View PDFchevron_right
In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity
Gary Landucci
Journal of Immunological Methods, 1998
View PDFchevron_right
Interactions between vaccinia virus and sensitized macrophagesin vitro
Ulrich Koszinowski
Archives of Virology, 1975
View PDFchevron_right
Adjuvants for Secretory Immune Responses*
M. Taubman
Annals of the New York Academy of Sciences, 1983
View PDFchevron_right
The specificity of antibody formation in mice following immunization with hapten-carrier complexes mixed with the surfactant, dimethyl dioctadecyl ammonium bromide
Harm Snippe
Immunology
View PDFchevron_right
Immunomodulation by bromocriptine
Sylvia L Asa
Immunopharmacology, 1983
View PDFchevron_right
Transmission and pathogenicity of encephalomyocarditis virus (EMCV) among rats
Charalambos Billinis
Veterinary Research, 2004
View PDFchevron_right
Mechanism of action of clinically approved adjuvants
Bart Lambrecht
Current Opinion in Immunology, 2009
View PDFchevron_right